Aanleiding
Uit diverse studies komt naar voren dat de vatbaarheid, het verloop en
de uitkomst van virusinfecties een samenhang lijkt te vertonen met tekorten aan
mineralen, vitamines en andere essentiele nutrienten.
Daarnaast zijn er studies die concluderen dat het nemen van supplementen
om deze tekorten op te heffen leidt tot een milder verloop danwel dat het helpt
om te voorkomen dat een virusinfectie zich voordoet.
Bijwerkingen van deze supplementen (ook wel nutraceuticals
genoemd) zijn er vaak niet in tegenstelling tot pharmaceuticals.
De 4 meest voorkomende tekorten worden hieronder behandeld en hangen
samen met het feit dat veel voedingspatronen eenzijdig zijn en bovendien vaak
geprocessed voedsel bevatten. Verder is er ook een verband tussen tekorten en
leeftijd, chronische ziekten en life style.
Soms is het nodig om met behulp van medicijnen de toegang tot een cel
voor een virus te blokkeren, gelukkig bestaan er goedkope en vrij (zonder
doktersrecept) verkrijgbare middelen.
Zink
Zink is zeer belangrijk voor het immuunsysteem (0).
Een chronisch of acuut zink-tekort kan ontstaan vanwege meerdere
redenen:
o
Het zink-absorptievermogen van mensen
neemt af naarmate men ouder wordt (1).
o
Zink-tekort kan ook ontstaan wanneer
men een chronische aandoening heeft waardoor er meer zink wordt verbruikt (2).
o
Een slordige life style kan oorzaak
zijn van een zink-tekort (bijvoorbeeld alcoholisme kan leiden tot een
zink-tekort) (3).
o
Er is een hoger verbruik van zink
tijdens een infectie wat kan leiden tot een acuut zink-tekort (4).
Bij een chronisch zink-tekort is een aanvulling middels
zink-supplementen op het dagelijks dieet noodzakelijk.
Over de positieve effecten van het innemen van zink-supplementen op:
o
long ontsteking bij kinderen (5).
o
long ontsteking bij ouderen (6).
o
COVID-19 “Wij stellen dat het menselijke
immuunsysteem perfect is uitgerust om het SARS-CoV-2-virus aan te pakken en dat
het COVID-19-geassocieerde sterftecijfer (C.F.R.) grotendeels kan worden
verminderd door de zink dieet inname te verbeteren en de zinkvormige absorptie
(via Zn2+-ionoforen voor ouderen – chloroquine, eventueel kinine of clioquinol)
te verbeteren” (7).
o
“Kan zink-correctie in
SARS-CoV-2 patiënten de resultaten van de behandeling verbeteren?” (8)
o
COVID-19 “Behandeling niet-IC
patiënten met zink vs zonder zink is 2x zo effectief”(9)
Een zink-correctie kan plaatsvinden middels supplementen echter naast een zink-supplement is er een
zogenaamde zink-ionofoor nodig om zink in de cel te krijgen.
Voorbeelden van zink-ionoforen
zijn: Chloroquine (CQ), HydroxyChloroQuine (HCQ), Kinine, Quercetine (QCT).
Quercetine
Quercetine heeft geen heftige bijwerkingen en is voor iedereen als
supplement te koop terwijl de meeste andere zink-ionoforen, zoals CQ, HCQ en
Kinine, alleen op doktersrecept verkrijgbaar zijn (deze zijn dan vaak wel
krachtiger maar geven wat meer kans op bijwerkingen).
·
Quercetine gaat ontstekingen tegen (10).
·
Quercetine is een zink-ionofoor en
verbetert de zink-absorptie (11).
·
Vitamine C stimuleert de opname van
Quercetine (12).
Vitamine C
Bij infecties zijn supplementen van Vitamine C nuttig voor het optimaal
functioneren van het immuunsysteem (13).
Samen met Zink speelt Vitamine C een belangrijke rol in het
immuunsysteem (14).
Vitamine D
Ook Vitamine D is een belangrijke speler voor het immuunsysteem (15).
Uit een drietal studies blijkt de belangrijke rol die een vitamine-D-tekort
speelt in het verloop van COVID-19 :
·
“Vitamine D-tekort verhoogt
de incidentie van luchtweginfecties. Meer dan 1 miljard mensen wereldwijd
hebben een tekort aan vitamine D. Als een vitamine D-deficiëntie wordt
geassocieerd met incidentie of ernst van de SARS-CoV-2-infectie, zou een
wereldwijde oproep kunnen worden gedaan voor vitamine D-supplementatie
om de pandemie te beperken.” Conclusie
uit een Belgisch onderzoek onder 186 COVID-19 patiënten is dat met name bij
mannen een vitamine-D-tekort sterk samenhangt met de incidentie en het stadium
van de ziekte zoals zichtbaar op een CT-scan (16).
·
Conclusie uit een Fillipijns
onderzoek onder 212 COVID-19 patiënten is dat een negatief verloop sterk
samenhangt met het vitamine-D-tekort (17).
·
Conclusie uit een Indonesisch
onderzoek onder 780 COVID-19 patiënten is dat mortaliteit en vitamine-D-tekort
sterk samenhangen ook wanneer gecontroleerd wordt voor leeftijd, geslacht en
co-morbiditeit (18).
·
Conclusie uit een Israelisch
onderzoek onder 7807 personen is dat 782 COVID-19 positief testen juist met een
hoog vitamine-D-tekort (18a).
Broomhexine – OTC-medicijn
Broomhexine is een goedkoop en bovendien zonder recept vrij verkrijgbaar
medicijn een zogenaamd Over-The-Counter-(OTC)-medicijn. Uit recent onderzoek
blijkt dat Broomhexine de celtoegang voor een virus blokkeert (19). In
combinatie met HCQ werkt het nog beter (20). Ook
HCQ kent een virusblokkerende werking maar is in Nederland door het NHG nog
niet positief geadviseerd, zie ook ons nieuwsblog hierover.
Deze onderzoeken zijn zogenaamde Randomised Control Trial (RCT) en maken
gebruik van laag gedoseerd HCQ wat nodig is om als zink-ionofoor te dienen.
Omdat HCQ in Nederland door het NHG negatief wordt geadviseerd bij COVID-19 kan
een vervangende zink-ionofoor gebruikt worden in de vorm van Quercetine (zie
hierboven).
Voor een advies over supplement en OTC-medicijn doseringen afhankelijk
van uw situatie lees verder op de pagina over Zelfzorg
Behalve via supplementen kunnen bovenstaande mineralen, vitamines en
nutrienten ook via voedingsmiddelen ingenomen worden. Een uitgebreidere
beschrijving van deze voedingsmiddelen vindt u op de pagina over Voeding.
Geplakt uit <https://zelfzorgcovid19.nl/>
Vitamin D could
have prevented 90% of coronavirus deaths
Tuesday, December 29, 2020 by: Ethan Huff
Tags: CCP, China Virus, Chinese
Communist Party, Chinese Virus, coronavirus, covid-19, deaths, goodhealth, goodmedicine, goodscience, Origins Nutrition
Center, pandemic, Peter Osborne, Plandemic, prevention, Study, vitamin D, Wuhan coronavirus
(Natural News) People everywhere are dropping dead from the Wuhan coronavirus (COVID-19), we are told, and the only solution is to get an “Operation Warp Speed” vaccine – except this is not the only solution. A much safer and more effective alternative remedy is to simply take vitamin D.
The latest scientific research shows that nine out
of 10 “COVID-19 deaths” could have been prevented if only the victims had
supplemented with vitamin D3 or gotten out in the sun more rather than
listening to Anthony Fauci and panicking.
Vitamin D deficiency, it turns out, significantly
increases a person’s risk of dying with COVID-19, and most Americans are
vitamin D deficient, sad to say.
The vitamin D prohormone helps to prevent the type
of hyper-inflammation that comes about from a COVID-induced cytokine storm, the
latest data shows. Vitamin D also helps to protect against the need for a
ventilator, a high-risk Western medicine intervention that has been known to
kill patients who are admitted to the hospital after testing positive for the
novel virus.
“I think that’s probably one of the smartest things
that a person could do right now, with an unpredictable role of a relatively
unknown illness,” says Dr. Peter Osborne from Origins Nutrition Center in Sugar
Land, Tex., about vitamin D supplementation.
“What we do know at this point about vitamin
therapy, particularly about vitamin D, a new study has come out and a new
analysis has come out on what we know about vitamin D and COVID.”
Dr. Osborne recommends taking not just D but C, but
zinc and quercetin too
Having to go on a ventilator is “not a good thing,” Dr. Osborne warns. The outcomes “aren’t great,” and there really is no reason to use a ventilator at all when “we can keep their immune system supported really well with nutrition.”
“That ideally makes the most sense,” he contends
about the use of vitamin D as a natural treatment.
The number of COVID-19 “cases” could be on the rise simply because the Northern Hemisphere is now in the throes of winter, which means people who live there now have minimal exposure to ultraviolet rays from the sun, which naturally produce vitamin D in the skin.
UV light, by the way, is already being used in some hospital settings to treat patients without drugs or
vaccines, and with incredible success. Some hospitals are also administering
vitamin D to their sick patients and seeing positive results.
“At the East Virginia School of Medicine, there’s a
COVID protocol that includes vitamin D,” Dr. Osborne says.
At this particular facility, patients are given a
daily regimen of between 20,000 and 60,000 international units (IU) of vitamin
D as part of their standard care protocol.
“With vitamin D, there’s a therapy that can be done
that I recommend, and it’s 1,000 international units of vitamin D per pound,”
Dr. Osborne says.
“So, if you’re 100 pounds, you would take 100,000
international units of vitamin D for three days. After that, you don’t have to
keep taking those higher doses, but three days of high-dose vitamin D will
elevate your serum vitamin D levels to adequate levels.”
Dr. Osborne also recommends supplementing with vitamin C, zinc and quercetin, the latter bioflavonoid nutrient effectively opening up the cells inside the body so enough zinc can get inside.
Other natural sources of vitamin D that Dr. Osborne
recommends include cod liver oil, fatty fish and mushrooms, though getting
enough vitamin D from these sources requires their heavy consumption.
“Vitamin D is very inexpensive,” Dr. Osborne notes.
“You can buy it at the local nutrition store, and it might just save your life,
should you get sick.”
To learn more about how vitamin D and other natural
supplements can help you heal while keeping you healthy and protected against
disease, be sure to check out NaturalCures.news.
Sources for this article include:
Bron: https://www.naturalnews.com/2020-12-29-vitamin-d-prevents-90-percent-coronavirus-deaths.html
-----------------------------------------------------------------
Vitamin D
deficiency is the primary cause of covid hospitalizations and deaths
Wednesday, March 31, 2021 by: Lance D Johnson
Tags: badhealth, covid-19, exposure, immune system, infection recovery, malnourishment, melanin, nursing homes, nutrients, outbreak, outdoor living, pandemic, Public Health, risk factors, sendentary life, sunlight exposure, vitamin D, vitamin D deficiency, vitamin D levels, vitamins
A board-certified pathologist is speaking out about
the underlying cause of covid hospitalizations and deaths. Dr. Ryan Cole is the
founder of Cole Diagnostics, one of the largest independent laboratories in
Idaho. He has studied the real reasons why people suffer from infections. Vitamin D deficiency, which plagues approximately 70 percent of the world’s population, is
the real public health issue at hand.
“Normal D levels decrease your COVID symptom
severity risk for hospitalization by 90 percent. There have been a lot of placebo-controlled trials that show this all
around the world. It is scientific fact, not just a correlation,” said Dr.
Cole. “Data shows what kills people. Cytokine storm. If you are in (Vitamin D) mid-level range, you will not die from COVID
because you cannot get a cytokine storm.”
Vitamin D deficiency (and covid severity) is prevalent for these groups of people
Some specific groups have more vitamin D deficiency than other people.
African Americans and people with dark skin
Vitamin D deficiency is disproportionate among
different races and ethnicity. The melanin content of the skin is a determining
factor for how well people absorb the sun’s rays, leading to varying levels of
vitamin D production within the skin. Vitamin D deficiency affects roughly 47
percent of Caucasians, 70 percent of Latinos, 72 percent of Native Americans
and 83 percent of African Americans. Covid-19 has adversely affected African
Americans because their skin is not adept to assimilate vitamin D efficiently.
This is not a social disparity, as the media advertises. This is a biological
issue, one that should prompt every health authority to encourage the African
American community to get more sunlight and supplement with vitamin D during
the winter months.
Obesity and old age
Vitamin D deficiency is prevalent for people who
are obese, which is one of the other risk categories for severe covid illness.
Because vitamin D is a fat-soluble vitamin, it is readily stored in fat cells.
Circulating vitamin D levels are higher in people who have a healthy weight.
Vitamin D levels are low for elderly people who
live a sedentary life or for those who are confined to a dark nursing home
environment. “Ninety percent of deaths in the state have been over 70 years of
age. That’s the at-risk population,” said Dr. Cole. “We have stopped our
society for something that’s taking people that are already at that death risk
age anyway.” He added, “96 percent of people in the ICU are Vitamin D
deficient.”
People living in the Northern Hemisphere
Vitamin D deficiency also affects more people in
the Northern hemisphere because these populations typically spend less time in
the sun. One reason hospitalization will remain high in the North is because people spend more of their time indoors,
avoiding the long cold winters and staying away from the sunlight.
Florida, despite its high density, aging population, continues to handle covid-19 more effectively than all the northern states that are locked down, holding people in bondage. Even though Florida has been criticized for being a free and open state, the population was able to have a lower hospitalization and mortality rate because the people have more access to sunlight throughout the year. The warm temperatures are an opportunity for people to get more sun and have a stronger immune system naturally. The spread of viruses is of little concern if healthy people are overcoming the infection more rapidly, as their immune systems become equipped with higher vitamin D levels.
Public health authorities are taking the wrong
approach to public health
No one is entitled to live in a virus safe space,
nor is this avoidance approach the most effective and safe approach for
overcoming infectious disease. Raising the vitamin D level of people and
encouraging exposure could more rapidly help the population overcome the virus.
The inevitability of virus exposure is not something anyone can completely
control anyway. Public health authorities haven taken the wrong approach to
public health by restricting, socially ostracizing, and shaming people for
spreading infections they do not have, for which there is no evidence, for
which no viral load exists in their body. People with normal vitamin D levels
overcome the infection and gain immunity.
No one can vaccinate their way out of a vitamin D
deficiency. If vitamin D deficiency was adequately addressed, then the demand
for vaccines would be nil. The science of vitamin D is often ignored because
vaccines need to be profited from and worshiped as the end-all, holy grail of
science. Anything else that is more helpful to the body is suppressed and censored to coerce submission to a false savior
(vaccines) that carries their own set of risks. There’s no vitamin D mandate,
no vitamin D passport system, and no distribution of vitamin D across the country, even though clinical and hospital settings are
having tremendous success treating deficiencies and helping patients recover
from infection.
Sources include:
Geplakt uit <https://www.naturalnews.com/2021-03-31-vitamin-d-deficiency-cause-covid-hospitalizations-deaths.html>
------------------------------------------------------
GET OUTSIDE:
Sunlight inactivates Wuhan coronavirus 8 times faster than previously
predicted, researchers found
Monday, April 05, 2021 by: Virgilio Marin
Tags: anti-viral, covid-19, discoveries, goodhealth, goodmedicine, goodscience, infections, natural antibiotics, prevention, radiation, research, sunlight, Ultraviolet light, UV disinfection, UVA radiation, UVB radiation, virus, virus inactivation, Wuhan coronavirus
Researchers found that sunlight inactivates the
Wuhan coronavirus (COVID-19) more than eight times more
quickly than
predicted. Paolo Luzzatto-Fegiz, a professor of mechanical engineering at
the University
of California, Santa Barbara (UC Santa Barbara), and his colleagues reviewed recent
studies that explored the effects of different bands of ultraviolet
(UV) light –
namely, UVA, UVB and UVC radiation – on SARS-CoV-2, the virus behind COVID-19.
UVA is weakest among the three while UVC
is the most energetic and has been shown to inactivate viruses such as
SARS-CoV-2. Nearly all of the UV radiation that reaches the surface is UVA
since all of UVC and most of UVB rays are absorbed by Earth’s ozone layer.
Sunlight’s ability
to inactivate viruses is often attributed to UVB, which
can kill microbes. One of the studies analyzed by the researchers, for
example, shows that SARS-CoV-2 becomes inactivated because UVB damages the
RNA of the virus.
This study showed that UVB light could inactivate
the virus in simulated saliva in around 20 minutes. But a study published a
month later than the previous showed that sunlight alone could inactivate the
virus in the same amount of time. This led the researchers to suspect that UVB-induced RNA
inactivation “might not be the whole story.”
Sunlight may be able to prevent infections
The second lab study showed that
sunlight inactivates viruses in saliva within 10 to 20 minutes of
exposure, just like UVB. Luzzatto-Fegiz and his team noted that the upper limit
of this range is more than eight times faster than predicted by
the first study’s theoretical models. Meanwhile, viruses
cultured in a growth medium are inactivated more than three times faster than
predicted.
In an article published in February in the
Journal of Infectious Diseases, the researchers wrote that SARS-CoV-2
would have to be several times more sensitive to UVB than any currently known
virus to make the theoretical models fit the lab study’s findings.
Alternatively, the researchers suggested that there could be another agent involved besides UVB. UVA, for example, might be playing a more active role than initially thought.
“People think of UVA as not having much of an effect, but it might be interacting with some of the molecules in the [saliva],” Luzzatto-Fegiz explained. Those molecules, in turn, could become highly reactive and interact with SARS-CoV-2, accelerating virus inactivation. This process is commonly applied in wastewater treatment. In a 2013 study, for example, researchers used UVA to disinfect wastewater.
Luzzatto-Fegiz and his team noted that if
SARS-CoV-2 turned out to be sensitive to weaker wavelengths of light, then
sunlight might be better able to mitigate
virus transmission outdoors over a broader range of latitudes and daytime hours than
previously thought. Areas far from the equator tend to receive little
amounts of solar radiation while the amount of sunlight that trickles
in the daytime decreases during dusk and dawn.
(Related: Homeland security scientist confirms that natural sunlight kills coronavirus.)
UVA radiation can also provide more accessible and safer methods of UV disinfection. Though UVC radiation can be manufactured, it is the most damaging form of UV light, raising safety concerns and limiting its practical applications.
“UVC is great for hospitals,” said Julie McMurry, a professor of environmental and molecular toxicology at Oregon State University and a co-author of the article. “But in other environments – for instance, kitchens or subways – UVC would interact with the particulates to produce harmful ozone.”
Yangying Zhu, a professor of mechanical engineering
at UC Santa Barbara and another co-author of the article, noted that there
are now widely available LED bulbs that are many times stronger
than sunlight. These lightbulbs can be used to accelerate virus
inactivation while UVA rays can be potentially used to augment air
filtration systems at a relatively low risk for human.
Overall, the researchers recommended additional experiments to fully ascertain the effects of different wavelengths of UV light on viruses placed in different mediums.
Learn more about novel strategies to prevent COVID-19 at NaturalHealth.news.
Sources include:
Bron: https://www.naturalnews.com/2021-04-05-sunlight-inactivates-coronavirus-8-times-faster.html
--------------------
Homeland security scientist confirms that natural sunlight kills coronavirus
Friday, May 01, 2020 by: Ethan Huff
Tags: China, Chinese Virus, coronavirus, covid-19, disease, global emergency, Global Pandemic, infection, infections, kills, novel coronavirus, outbreak, pandemic, sunlight, temperature, Ultraviolet, virus, William Bryan, Wuhan, Wuhan coronavirus
(Natural News) The best and simplest cure for the Wuhan coronavirus (COVID-19) might just be going outside, as natural sunlight contains ultraviolet (UV) rays that Department of Homeland Security (DHS) science and technology advisor William Bryan says easily destroy viruses.
During a recent press briefing at the White House,
Bryan explained how UV rays from the sun are powerfully antagonistic against
the Wuhan coronavirus (COVID-19), inhibiting its ability to survive, let alone
take hold and spread.
A study that looked at the three different types of
UV light given off by the sun – A, B, and C rays – found that UVC in particular
destroys certain types of genetic material in humans, including viral
particles. Based on this, the study found that UVC light can effectively
inactivate microbes like the Wuhan coronavirus (COVID-19).
“Our most striking observation to date is the
powerful effect that solar light appears to have on killing the virus, both on
surfaces and in the air,” Bryan is quoted as saying about the study’s findings.
“We’ve seen a similar effect with both temperature
and humidity as well, where increasing the temperature and humidity or both is
generally less favorable to the virus,” he added.
In an ordinary 70-75 degree (Fahrenheit)
environment with 20 percent humidity on a non-porous surface, the half-life for
the Wuhan coronavirus (COVID-19) is about 18 hours. Increasing the humidity to
80 percent, however, decreases that half-life to six hours, while adding
natural sunlight into the mix decreases it to just two minutes.
This would all suggest that simply being in the sun
more can help to reduce the risk of Wuhan coronavirus (COVID-19) infection and
transmission, as viruses simply cannot coexist with natural sunlight.
Listen below to The Health Ranger Report as
Mike Adams, the Health Ranger, talks about how to make antiviral colloidal
silver at home using silver coins:
Hospitals already use artificial UVC light to sterilize equipment
Artificial UVC light is already used in many
hospitals to sterilize surgical equipment and surfaces. It is also used to
clean airplanes and factories, as the science shows that potentially harmful
microbes are unable survive in its presence for any substantial length of time.
In the case of the Wuhan coronavirus (COVID-19),
the rhetoric will surely be that more testing is needed to determine how much
UVC light is necessary to destroy it. It also remains to be seen how much time
one would need to spend in natural sunlight to obtain these benefits.
At the same time, Bryan is still encouraging
Americans to follow stay-at-home orders – probably because he has to say this
in order to stick with the script.
“It would be irresponsible for us to say that we
feel that the summer is just going to totally kill the virus and then if it’s a
free-for-all and that people ignore these guides,” he stated in a somewhat
discombobulated way.
The World Health Organization (WHO), which just like Bill Gates only supports pharmaceuticals and vaccines for disease, is of course warning against UVC light, which it claims can burn the skin and cause eye damage.
Previous studies have identified that UVC light is effective against other coronaviruses such as SARS (severe acute respiratory syndrome), and that this particular type of radiation prevents viral particles from replicating. Researchers are also tinkering around with LED light, which may also be effective against viruses.
“One major application is in medical situations –
the disinfection of personal protective equipment, surfaces, floors, within the
HVAC systems, et cetera,” says materials doctoral researcher Christian Zollner
about UVC.
“UVC light in the 260 to 285nm range most relevant for current disinfection technologies is also harmful to human skin, so for now it is mostly used in applications where no one is present at the time of disinfection.”
To keep up with the latest news about the Wuhan coronavirus (COVID-19), be sure to check out Pandemic.news.
Sources for this article include:
----------------------------------
Over 200 doctors call for global vitamin D distribution because it inexpensively reduces covid infections, hospitalizations and deaths
Sunday, April 25, 2021 by: Lance D Johnson
Tags: #nutrition, b vitamins, covid nutrients, Cures, goodhealth, goodmedicine, goodscience, healing, immune deficiency, immune system, infection recovery, ivermectin, nitric oxide, nutrients, pandemic, prevent
hospitalization, prevention, remedies, selenium, supplements, vitamin C, vitamin D, vitamin D deficiency, zinc
(Natural News) Over two hundred doctors and scientists have come together in support of worldwide distribution of vitamin D to help treat covid infections and reduce hospitalizations, ICU admissions and deaths. The doctors are calling on all governments and healthcare systems around the world to immediately recommend and distribute vitamin D to adult populations.
Long before covid-19, most of the world’s
population was physically primed to suffer from infections. This is because 70
percent of the world’s population is deficient in vitamin D and have subpar
immune function. All current medical research shows that vitamin D deficiency
is the common denominator behind covid hospitalization, ICU admission, severe illness and death.
Vitamin D is both inexpensive and nontoxic. It
could have already been delivered worldwide to people throughout the pandemic,
but public health authorities from the NIH to the CDC shamefully took the
opposite approach, leading to needless suffering and death.
Addressing vitamin D deficiency should be top
priority for governments around the world
Vitamin D deficiency is medically defined as less than 20ng/ml (50nmol/L) and affects over 33 percent of the population. Vitamin D insufficiency is defined as less than 30ng/ml (75nmol/L) and affects over 50 percent of the population. In order to get circulating vitamin D to a minimally sufficient level (30ng/ml), most people are recommended to consume 6,200 international units (IU) of vitamin D each day.
Vitamin D deficiency is more common in people with dark skin, due to their high melanin content, which blocks sunlight absorption. Deficiency is also common for people who are overweight or obese. Vitamin D is fat soluble; therefore, circulating vitamin D levels are higher in people who have a healthy weight. People who live in the Northern Hemisphere are commonly deficient, especially in the winter, when they are indoors and away from the sunlight. The elderly population is also deficient, especially if they are stuck in nursing homes that cordon them off from sunlight.
The doctors .have analyzed over 188 scientific papers on vitamin D and concur:
• Higher vitamin D blood levels are associated with lower rates of
SARS-CoV-2 infection.
• Many papers indicate that vitamin D affects COVID-19 more strongly
than most other health conditions, with increased risk at levels less than
30ng/ml (75nmol/L) and severely greater risk at levels less than 20ng/ml
(50nmol/L).
• Higher D levels are associated with lower risk of a severe case
(hospitalization, ICU or death).
• Intervention studies and randomized controlled trials indicate that
vitamin D can be a very effective treatment.
• Many papers reveal several biological mechanisms by which vitamin D
influences COVID-19.
• Causal inference modelling, Hill’s criteria, the intervention studies
& the biological mechanisms indicate that vitamin D’s influence on COVID-19
is very likely causal, not just correlation.
• COVID-19 pandemic sustains itself in large part through infection of
those with low vitamin D, and that deaths are concentrated largely in those
with deficiency.
Addressing underlying immune deficiency is the most
important health responsibility
The doctors and scientists agree that all adults
should take 10,000 IU of vitamin D3 every day for at least two weeks to
get circulating vitamin D levels to a sufficient level in their blood. They
also recommend that every adult take 4,000 IU of vitamin D3 every day afterward
to maintain a healthy level. They recommend that high risk groups (dark skin,
excess weight) should take double that amount. Patients who are hospitalized
with covid-19 should be administered a higher dose, which was instrumental in
helping patients recover in two important 2020 studies.
Patients who received 60,000 IU vitamin D daily for 7 days were more likely to recover without complications or death.
The doctors also recommend vitamin C intake at 500 mg, twice daily. Since vitamin C is water soluble, it’s best to ingest it intermittently throughout the day. Whole food sources include citrus fruits, camu camu, and amalaki berry.
Most people are also deficient in the mineral selenium.
These doctors suggest 200 micrograms of selenium per day.
Zinc is equally
important for stopping viral replication and can be consumed in doses of 30 mg per day.
Quercetin, a natural plant pigment and antioxidant, can help zinc assimilate in the cells. The doctors recommend 250 mg, twice daily. Because severe covid illness shows signs of blood coagulation and thrombosis, the doctors recommend aspirin (325 mg/day) while symptoms lasts. Nitric oxide is also important for keeping oxygen levels up in the blood. The doctors recommend whole food B-complex vitamins, which are highly concentrated in foods like beet root and spirulina. For further treatment, the doctors recommend a prescription of ivermectin, a proven antiviral.
For more on conquering infection, check out VitaminD.News.
Sources include:
Bron: https://www.naturalnews.com/2021-04-25-200-doctors-call-for-global-vitamin-d-distribution.html
Over 200 Scientists & Doctors Call For Increased Vitamin D Use To Combat COVID-19
#VitaminDforAll (for
questions or fact checking assistance, contact press@vitaminDforAll.org)
Scientific evidence indicates vitamin D reduces infections & deaths
To all governments, public health officials, doctors, and healthcare workers,
[Residents of
the USA: Text “VitaminDforAll” to 50409 to send this to your state’s governor.]
Research shows
low vitamin D levels almost certainly promote COVID-19 infections,
hospitalizations, and deaths. Given its safety, we call for immediate
widespread increased vitamin D intakes.
Vitamin D
modulates thousands of genes and many aspects of immune function, both innate
and adaptive. The scientific evidence1 shows that:
·
Higher vitamin D blood levels are
associated with lower rates of SARS-CoV-2 infection.
·
Higher D levels are associated with lower risk of a
severe case (hospitalization, ICU, or death).
·
Intervention studies (including RCTs) indicate that
vitamin D can be a very effective treatment.
·
Many papers reveal several biological mechanisms by
which vitamin D influences COVID-19.
·
Causal inference modelling, Hill’s criteria, the
intervention studies & the biological mechanisms indicate that vitamin
D’s influence on COVID-19 is very likely causal, not just correlation.
Vitamin D is
well known to be essential, but most people do not get enough. Two common
definitions of inadequacy are deficiency < 20ng/ml (50nmol/L), the target of
most governmental organizations, and insufficiency < 30ng/ml (75nmol/L), the
target of several medical societies & experts.2 Too many people have
levels below these targets. Rates of vitamin D deficiency <20ng/ml
exceed 33% of the population in most of the world, and most estimates of
insufficiency <30ng/ml are well over 50% (but much higher in many
countries).3 Rates are
even higher in winter, and several groups have notably worse deficiency: the
overweight, those with dark skin (especially far from the equator), and care
home residents. These same groups face increased COVID-19 risk.
It has been shown that 3875 IU (97mcg) daily is required for 97.5% of people to reach 20ng/ml, and 6200 IU (155mcg) for 30ng/ml,4 intakes far above all national guidelines. Unfortunately, the report that set the US RDA included an admitted statistical error in which required intake was calculated to be ~10x too low.4 Numerous calls in the academic literature to raise official recommended intakes had not yet resulted in increases by the time SARS-CoV-2 arrived. Now, many papers indicate that vitamin D affects COVID-19 more strongly than most other health conditions, with increased risk at levels < 30ng/ml (75nmol/L) and severely greater risk < 20ng/ml (50nmol/L).1
____________________________
1 The evidence
was comprehensively reviewed (188 papers) through mid-June [Benskin ‘20] & more recent
publications are increasingly compelling [Merzon et al ‘20; Kaufman et al ‘20; Castillo et al ‘20]. (See also [Jungreis & Kellis ‘20] for deeper analysis of
Castillo et al’s RCT results.)
2 E.g.:
20ng/ml: National Academy of Medicine (US, Canada), European Food Safety
Authority, Germany, Austria, Switzerland, Nordic Countries, Australia, New
Zealand, & consensus of 11 international organizations. 30ng/ml:
Endocrine Society, American Geriatrics Soc., & consensus of scientific experts. See also [Bouillon ‘17].
3 [Palacios & Gonzalez ‘14; Cashman
et al ‘16; van Schoor & Lips ‘17] Applies to China, India,
Europe, US, etc.
4 [Heaney
et al ‘15; Veugelers & Ekwaru ‘14]
______________________________
Evidence to date suggests the possibility that the COVID-19 pandemic sustains itself in large part through infection of those with low vitamin D, and that deaths are concentrated largely in those with deficiency. The mere possibility that this is so should compel urgent gathering of more vitamin D data. Even without more data, the preponderance of evidence indicates that increased vitamin D would help reduce infections, hospitalizations, ICU admissions, & deaths.
Decades of
safety data show that vitamin D has very low risk: Toxicity would be
extremely rare with the recommendations here. The risk of insufficient levels
far outweighs any risk from levels that seem to provide most of the protection
against COVID-19, and this is notably different from drugs. Vitamin D is much safer
than steroids, such as dexamethasone, the most widely accepted treatment to
have also demonstrated a large COVID-19 benefit. Vitamin D’s safety is more
like that of face masks. There is no need to wait for further clinical
trials to increase use of something so safe, especially when remedying
high rates of deficiency/insufficiency should already be a priority.
Therefore, we call on all governments, doctors, and healthcare workers worldwide to immediately recommend and implement efforts appropriate to their adult populations to increase vitamin D, at least until the end of the pandemic.
Specifically to:
1. Recommend
amounts from all sources sufficient to achieve 25(OH)D serum levels
over 30ng/ml (75nmol/L), a widely endorsed minimum with evidence of reduced
COVID-19 risk.
2. Recommend to
adults vitamin D intake of 4000 IU (100mcg) daily (or at least
2000 IU) in the absence of testing. 4000 IU is widely regarded as safe.5
3. Recommend that
adults at increased risk of deficiency due to excess weight, dark skin, or
living in care homes may need higher intakes (eg, 2x). Testing can help to
avoid levels too low or high.
4. Recommend that
adults not already receiving the above amounts get 10,000 IU (250mcg) daily for
2-3 weeks (or until achieving 30ng/ml if testing), followed by the daily
amount above. This practice is widely regarded as safe. The body can
synthesize more than this from sunlight under the right conditions (e.g.,
a summer day at the beach). Also, the NAM (US) and EFSA (Europe) both
label this a “No Observed Adverse Effect Level” even as a daily maintenance
intake.
5. Measure 25(OH)D
levels of all hospitalized COVID-19 patients & treat w/ calcifediol or
D3, to at least remedy insufficiency <30ng/ml (75nmol/L), possibly with
a protocol along the lines of Castillo et al ‘20 or Rastogi et al '20, until
evidence supports a better protocol.
Many factors
are known to predispose individuals to higher risk from exposure to SARS-CoV-2,
such as age, being male, comorbidities, etc., but inadequate vitamin
D is by far the most easily and quickly modifiable risk factor with
abundant evidence to support a large effect. Vitamin D is inexpensive and
has negligible risk compared to the considerable risk of COVID-19.
Please Act Immediately
_____________________________
5 The
following include 4000 IU within their tolerable intakes in official
guidelines: NAM (US, Canada), SACN (UK), EFSA (Europe), Endocrine Society
(international), Nordic countries, The Netherlands, Australia & New
Zealand, UAE, and the American Geriatrics Soc. (USA, elderly). No major agency
specifies a lower tolerable intake limit. The US NAM said 4000 IU “is likely to
pose no risk of adverse health effects to almost all individuals.” See also [Giustina
et al ‘20].
______________________________
The signatories below endorse this letter. Affiliations do not imply endorsement of the letter by the institutions themselves.
This letter
takes no position on other public health measures besides vitamin D. Personal
views of individual signatories on any other matter do not represent the group
as a whole.
All signatories
declare no conflicts of interest except as noted.
To emphasize: The
organizing signatories have no conflicts of interest in this area (financial or
otherwise), nor have they done research in this area prior to 2020.
|
Signatories
(220 total; other counts at the end) |
|
Dr. Karl
Pfleger, PhD AI
& Computer Science, Stanford. Former Google Data Scientist. Biotechnology
Investor, AgingBiotech.info, San Francisco, CA, USA. (organizing signatory) |
|
Dr. Gareth
Davies, PhD Medical
Physics, Imperial College, London, UK. Codex World’s Top 50 Innovator 2019.
Independent Researcher. Lead author of “Evidence
Supports a Causal Role for Vitamin D Status in COVID-19 Outcomes.” (organizing signatory) |
|
Dr. Bruce W
Hollis, PhD.
Professor of Pediatrics, Medical University of South Carolina, USA. |
|
Dr. Barbara J
Boucher, MD, FRCP
(London). Honorary Professor (Medicine), Blizard Institute, Bart's &
The London School of Medicine and Dentistry, Queen Mary University of London,
UK. (significantly
contributing signatory) |
|
Dr. Ashley
Grossman, MD FRCP
FMedSci. Emeritus Professor of Endocrinology, University of Oxford, UK.
Professor of Neuroendocrinology, Barts and the London School of Medicine. 2020 Endocrine Society
Laureate Award. |
|
Dr. Gerry
Schwalfenberg, MD, CCFP, FCFP. Assistant Clinical Professor in Family Medicine,
University of Alberta, Canada. |
|
Dr. Giovanna
Muscogiuri, MD PhD. Associate Editor, European Journal of Clinical
Nutrition. Department of Clinical Medicine and Surgery, Section of
Endocrinology, University "Federico II" of Naples, Naples, Italy.. |
|
Dr. Michael
F. Holick, PhD MD. Professor Medicine, Physiology and Biophysics and Molecular
Medicine, Director Vitamin D, Skin and Bone Research Laboratory, Boston
University Medical Center, USA. (6000 IU) Disclosure: Consultant
Biogena and speaker's Bureau Abbott Inc. |
|
Dr. John
Umhau, MD, MPH.
CDR, USPHS (ret). President, Academy of Medicine of Washington, DC, USA.
Ex-NIH: co-author of the first peer-reviewed report linking vitamin D
deficiency with acute respiratory infection. (significantly contributing
signatory) |
|
Dr. Pawel Pludowski, MD, dr hab.
Associate Professor, Biochemistry, Radioimmunology and Experimental Medicine,
Children’s Memorial Health Institute, Warsaw, Poland. Chair, European Vitamin D
Association (EVIDAS) [non-profit]. |
|
Dr. Cedric F.
Garland, DrPH.
Professor Emeritus, Department of Family Medicine and Public Health,
University of California, San Diego, USA. |
|
Dr. Jose M.
Benlloch, PhD.
Professor, Director of the Institute for Instrumentation on Molecular
Imaging, CSIC-UPV, Valencia, Spain. |
|
Dr. Samantha
Kimball, PhD, MLT.
Professor, St. Mary's University, Calgary, Alberta, Canada. Research
Director, GrassrootsHealth Nutrient Research Institute [non-profit]. (significantly
contributing signatory) |
|
Dr. William
B. Grant, PhD
Physics, U. of California, Berkeley. Director at Sunlight, Nutrition, and
Health Research Center [non-profit], San Francisco, CA, USA. Disclosure: Receives funding
from Bio-Tech Pharmacal, Inc. |
|
Dr. Carol L.
Wagner, MD.
Professor, Medical University of South Carolina, USA. |
|
Dr. Paul
Marik, MD, FCCP,
FCCM. Chief of Pulmonary and Critical Care Medicine and Professor of
Medicine, Eastern Virginia Medical School, Norfolk, VA, USA. |
|
Dr. Morry
Silberstein, MD. Associate Professor, Curtin University, Australia. |
|
Dr. Vatsal
Thakkar, MD.
Founder, Reimbursify, NY, USA. Former faculty, NYU and Vanderbilt.
Op-Ed writer on Vitamin D and COVID-19. (significantly contributing
signatory) |
|
Dr. Peter H
Cobbold, PhD.
Emeritus Professor, Cell Biology, University of Liverpool, UK. |
|
Dr. Afrozul
Haq, PhD.
Professor Dept of Food Technology, Jamia Hamdard University, New Delhi,
India. |
|
Dr. Barry H.
Thompson, MD, FAAP,
FACMG. Clinical Associate Professor (Pediatrics), Uniformed Services
University of the Health Sciences, Bethesda, MD, USA. |
|
Dr. Reinhold
Vieth, PhD, FCACB.
Professor, Departments of Nutritional Sciences and Laboratory Medicine &
Pathobiology, University of Toronto, Canada. Director (retired), Bone and
Mineral Group Laboratory, Mt Sinai Hospital. Disclosure: Receives
patent royalties from Ddrops (an infant vitamin D supplement). |
|
Dr. Linda
Benskin, PhD, RN,
SRN(Ghana), CWCN, CWS, DAPWCA. Independent Researcher for Tropical Developing
Countries and Ferris Mfg. Corp, Texas, USA. (significantly contributing
signatory) |
|
Jim O’Neill, CEO, SENS
Research Foundation. Former principal associate deputy secretary of Health
and Human Services, USA. |
|
Dr. Eric
Feigl-Ding, PhD. Epidemiologist & Health Economist. Senior Fellow,
Federation of American Scientists. USA. |
|
Rt Hon David
Davis MP, Member of
Parliament (Conservative Party). BSc, Joint Hons Molecular Science / Computer
Science, Warwick University, UK. |
|
Dr. Rupa Huq
MP, Member
of Parliament (Labour Party). PhD, Cultural Studies, University of East
London, UK. |
|
Dr. Susan J
Whiting, PhD.
Professor Emerita, University of Saskatchewan, Canada. |
|
Dr. Richard
Mazess. PhD.
Emeritus Professor, University of Wisconsin, Madison, USA. |
|
Dr. Helga
Rhein, MD
(retired). Sighthill Health Centre, Edinburgh, UK. (significantly contributing
signatory) |
|
Dr. Andrea
Doeschl-Wilson, PhD. Professor of Infectious disease genetics and modelling, The
Roslin Institute, University of Edinburgh, UK. |
|
Dr.
Ute-Christiane Meier, Dr med habil, PhD (Oxon), Dipl-Biol. Visiting
lecturer, Institute of Psychiatry, Psychology & Neuroscience, King's
College, London, UK and Privatdozentin, Ludwig Maximilian University of
Munich, Germany. Disclosure: Patent 20160131666: "Biomarkers
for inflammatory response." |
|
Dr. Luigi
Gennari, MD PhD. Full
Professor, Internal Medicine, Department of Medicine, Surgery and
Neurosciences, University of Siena, Siena, Italy. |
|
Dr. Ased Ali, MBChB, PhD,
FRCS. Consultant Urological Surgeon, Mid Yorkshire Hospitals NHS Trust, UK. |
|
Dr. Pavel
Kocovsky, PhD DSc
FRSE FRSC. Professor Charles University, Prague, and Czech Academy of
Sciences, Czech Republic. |
|
Dr. Ace
Lipson, MD.
Endocrinologist. Clinical Professor, George Washington University,
Washington, DC, USA. |
|
Dr. Attila R Garami, MD, PhD Multidisciplinary
Medical Sciences. Senior Biomarker Consultant, Switzerland. |
|
Dr. David S
Grimes,
MD (retired), FRCP, University of Manchester, UK. |
|
Dr. Larry
Callahan, PhD.
Chemist, FDA, Maryland, USA. |
|
Dr. Jeanne M
Marconi, MD,
Pediatrics. Vice
President of PM Pediatrics, New York, USA. |
|
Dr. Spiros
Karras, MD.
Endocrinologist, Department of Endocrinology and Metabolism-Diabetes Center,
1st Department of Internal Medicine, AHEPA University Hospital, Thessaloniki,
Greece. |
|
Dr. Joanna
Byers, MBChB,
University of Birmingham, UK. |
|
Dr. Jaimin
Bhatt, MBChB,
MMed(Surgery) FRCS(Urol) FEBU. Consultant Urological Surgeon, Queen
Elizabeth University Hospital, NHS Greater Glasgow and Clyde, UK. (2000 IU) |
|
Dr.
Christiane Northrup, MD. Obstetrician/Gynecologist, USA. |
|
Dr. Jörg Spitz, Dr med. Academy of
Human Medicine, Schlangenbad, Germany. |
|
Dr. Naghmeh
Mirhosseini, MD, PhD, MPH. Research Associate, School of Public Health,
University of Saskatchewan, Canada.. |
|
Dr. Iacopo
Chiodini, MD.
Associate Professor of Endocrinology, Dept. of Medical Biotechnology and
Translational Medicine, University of Milan, Milan, Italy. Head, Unit for
Bone Metabolism Diseases and Diabetes, Istituto Auxologico Italiano, IRCCS,
Milan, Italy. |
|
Dr. David C
Anderson, MD MSc FRCP
FRCPE FRCPath. Retired Physician and Endocrinologist, Former Professor of
Endocrinology, Manchester University, UK and Professor of Medicine, The
Chinese University of Hong Kong. |
|
Dr. Colin Bannon, MBChB. GP (retired),
Devon, UK. |
|
Dr. Patricia
S. Latham, MD EdD. Professor of Pathology & Medicine, George Washington
University School of Medicine and Health Sciences, Washington, DC, USA. |
|
Dr. Teresa
Fuller, MD PhD.
Pediatrician, Owings Mills, MD, USA. |
|
Dr. Omar Wasow, PhD, Harvard. Assistant
Professor, Politics, Princeton University, NJ, USA. |
|
Dr. Fabio
Vescini, MD PhD. Endocrinology
and Metabolism Unit, University-Hospital S. Maria della Misericordia, Italy. |
|
Dr. Emily
Grossman, PhD
Molecular Biology, University of Manchester, UK. Science Author, Broadcaster
and Educator. |
|
Dr. David
Carman, MBChB,
University of Cape Town, South Africa. |
|
Dr. Kalliopi
Kotsa, MD PhD.
Professor, Endocrinology-Diabetes, Dept of Medicine, Aristotle University,
Thessaloniki, Greece. |
|
Dr. Eva
Kocovska, PhD,
Queen Mary University of London. Gillberg Neuropsychiatry Centre, University
of Gothenburg, Sweden. Medical College, Prague, Czech Republic. |
|
Dr. Benjamin
Jacobs, MBBS MD
MRCP(UK) FRCPCH. Royal National Orthopaedic Hospital, UK. |
|
Dr. Joan Lappe, PhD RN FAAN. Professor,
Creighton University, Omaha, Nebraska, USA. |
|
Dr. Ronald A.
Primas, MD FACP
FACPM DABIHM CTH. New
York, NY, USA. |
|
Dr. Cristina
Eller Vainicher,
MD. Unit of
Endocrinology, Fondazione Ca'Granda IRCCS OSpedale Maggiore Policlinico
Milan, Italy. Head of the
outpatients clinic for osteoporosis. |
|
Dr. Matthias Gauger, MD. General Practitioner,
Switzerland. |
|
Dr. David
Warwick, DDS.
Dentist, Alberta, Canada. Published Researcher. |
|
Dr. Sunil J.
Wimalawansa, MD PhD MBA FRCP FRCPath FACE FACP DSc. Professor of Medicine,
Endocrinology & Nutrition, Cardiometabolic & Endocrine Institute, New
Jersey, USA. |
|
Perry S.
Holman. Executive
Director, Vitamin D Society [non-profit], Canada. |
|
Sharon McDonnell, MPH. Biostatistician,
GrassrootsHealth Nutrient Research Institute [non-profit], Encinitas, CA,
USA. |
|
Mike Fischer. Founder,
VitaminDassociation.org [non-profit]. Director of Research, Systems Biology
Laboratory, UK. |
|
Dr. Lina
Zgaga, MD, PhD.
Associate Professor of Epidemiology, Trinity College Dublin, University of
Dublin, Ireland. |
|
Dr. Irwin
Jungreis, PhD,
Harvard University. Research Scientist, Massachusetts Institute of
Technology, Cambridge, MA, USA. |
|
Dr. Jane Coad, PhD.
Professor of Nutrition, Massey University, New Zealand. |
|
Dr. Cedric
Annweiler, MD PhD. Professor of Geriatric Medicine, School of Medicine, Health
Faculty, University of Angers and Department of Medicine, Clinique de
l’Anjou, Angers, France. Disclosure: occasional consultant for Mylan
Laboratories Inc. |
|
Dr. Salvatore
Minisola, MD. Full
Professor of Internal Medicine, "Sapienza" Rome University, Italy. |
|
Dr. Mats B.
Humble, MD PhD. Psychiatrist
(retired), Senior lecturer, Department of Medical Sciences, Örebro
University, Sweden. |
|
Dr. Andrea
Fabbri, MD PhD.
Professor of Endocrinology, Head Endocrinology Division, Ospedale CTO A.
Alesini, University of Rome Tor Vergata, Rome, Italy. |
|
Dr. Steve Jones, PhD FRS. Emeritus
Professor of Human Genetics, Dept of Genetics, Evolution and Environment,
University College London, UK. |
|
Dr. Hermann
Brenner, MD MPH.
Professor of Epidemiology, Head of Clinical Epidemiology and Aging Research,
German Cancer Research Center, Heidelberg, Germany. |
|
Dr. Helder F.
B. Martins, MD PhD (hon).Specialist & Emeritus Professor of Public Health.
Former Minister of Health, Mozambique. Former WHO. Member, Mozambican
Government COVID-19 advisory committee. |
|
Dr. G. Siegfried Wedel, MD. Internist-Nephrologist
(retired), Vierhöfen, Germany. |
|
Dr. Robin
Weiss, PhD FRCPath
FMedSci FRS. Emeritus Professor of Viral Oncology, Division of Infection
& Immunity, University College London, UK. |
|
Dr. Giancarlo
Isaia, MD. Full
Professor, University of Turini. President of the Academy of Medicine of
Turin, Italy. |
|
Dr. Susanne
Bejerot, MD.
Professor, Örebro University, Sweden. |
|
Dr. Antonio
D'Avolio, PhD.
Professor of Pharmacology, University of Turin, Italy. |
|
Dr. Gustavo
Duque, MD PhD
FRACP FGSA. Chair of Medicine & Director of the Australian Institute for
Musculoskeletal Science (AIMSS). The University of Melbourne and Western Health,
Melbourne, Australia. |
|
Dr. Giovanni
Passeri, MD PhD. Associate
Professor, Internal Medicine, Dep. of Medicine and Surgery, University of
Parma, Parma, Italy. |
|
Dr. Pankaj
Kapahi, PhD.
Professor, Buck Institute for Research on Aging, Novato, California, USA. |
|
Dr. Giuseppe
Poli, MD PhD. Emeritus
Professor of General Pathology, University of Turin, Italy. |
|
Dr. Patrick
McCullough, MD. Chief of Medical Services, Summit Behavioral Healthcare,
Cincinnati, Ohio USA. |
|
Dr. Prashanth
Kulkarni, MD DM FSCAI
FACC. Consultant Cardiologist, Hyderabad, India. |
|
Dr. Klaus Badenhoop, MD PhD. Professor,
Division of Endocrinology & Diabetes, Department of Internal Medicine,
Goethe-University Hospital, Frankfurt am Main, Germany. |
|
Dr. José-María
Sánchez-Puelles,
PhD. Senior
Researcher, CIB Margarita Salas, CSIC, Spain |
|
Dr. Carmelinda Ruggiero, MD PhD. Professor of
Geriatric Medicine, School of Medicine, University of Perugia, Italy. Head of
the Orthogeriatric Unit, S Maria Misericordia Teaching Hospital, Perugia,
Italy. Disclosure:
Occasional consultant for UCB Pharma. |
|
Dr. Jose
Manuel Quesada Gomez, MD, PHD, Honorary Professor, University of
Cordoba. Maimonides
Research Institute, Cordoba. Spain. |
|
Dr. Giovanni
Minisola, MD.
President Emeritus of Italian Society for Rheumatology. Scientific Director of
"San Camillo - Forlanini" Foundation, Rome, Italy. |
|
Christine
French, MS.
Research Analyst at GrassrootsHealth Nutrient Research Institute
[non-profit], Encinitas, CA, USA. |
|
Dr. Patrizia
Presbitero, MD. Clinical and interventional cardiology, Cardio Center, Humanitas
Research Hospital Rozzano, Rozzano, Milan, Italy. |
|
Dr. Ken
Redcross, MD. Doctor
and on-camera medical expert, New York, USA. Disclosure: scientific
advisory board of the Organic & Natural Health Association. |
|
Dr. Rajeev
Venugopal, MBBS FRCS FACS DM. Consultant Plastic Surgeon/ Associate Lecturer in
Surgery, University of the West Indies at Mona, Jamaica. |
|
Dr. Gianluca
Isaia, MD PhD.
Geriatrician, Section of Geriatrics, Department of Medical Sciences,
University of Turin, A.O.U. Città della Salute e della Scienza di Torino,
Molinette, Turin, Italy. |
|
Dr. Piero
Stratta,
MD. Professor of Nephrology, University Piemonte Orientale, Italy. |
|
Dr. Ben
Schöttker, PhD. Scientist, Division of Clinical Epidemiology and Ageing
Research, German Cancer Research Center, Heidelberg, Germany. |
|
Dr. Roberto
Fantozzi, MD. Full
Professor of Pharmacology, University of Turin, Turin, Italy. |
|
Dr. Sheryl L
Bishop, PhD.
Professor Emeritus, University of Texas Medical Branch, School of Nursing,
Galveston, Texas, USA. |
|
Dr. Wayne
Jonas, MD.
Professor of Family Medicine, Georgetown University. Former Director NIH Office
of Alternative Medicine, USA. |
|
Dr.
Ferdinando Silveri, Medical Director of the Rheumatology Clinic of
the Marche Polytechnic University, Ancona, Italy. |
|
Dr. Vatsalya
Vatsalya, MD.
Department of Medicine, University of Louisville. National Institute on
Alcohol Abuse and Alcoholism NIH, USA. |
|
Dr. Rachel
Nicoll, PhD.
Medical researcher, Umeå University, Sweden. |
|
Dr. Fausto
Crapanzano, MD, Physical Medicine and Rehabilitation. Chief, MFR Department,
Provincial Health Authority, Agrigento, Italy. |
|
Dr. Raimund von Helden, Dr med. Family
medicine. Institute VitaminDelta, Lennestadt, Germany. Disclosure:
Institute VitaminDelta sells consumer advice including on vitamin D for
modest cost, but with no ties to other commercial interests. |
|
Carole
Baggerly, Founder
& Director, GrassrootsHealth Nutrient Research Institute [non-profit],
Encinitas, CA, USA. |
|
Dr. Edward
Gorham, PhD MPH.
Adjunct Professor, University of California San Diego, School of Medicine,
Dept of Family Medicine and Public Health, USA. |
|
Dr. David Verhaeghen, MD,
Anesthesiology, Algology and Pain Medicine, Aalst, Belgium. |
|
Dr. Silvia
Migliaccio, MD PhD. Associate Professor at University Foro Italico of
Roma, Italy. Secretary of the
Italian Society of Food Sciences. |
|
Dr. Vítor
Oliveira, MD, Internal
Medicine, Brazil. |
|
Dr. Djamel
Deramchi, MD.
Functional medicine. GrassrootsHealth Certified Vitamin D*practitioner and
Coimbra Protocol Certified Doctor. France. |
|
Dr. William
Shaver, MD.
Physician, Gastroenterologist, Lubbock, TX, USA. |
|
Dr. Wim
Soetaert, PhD. Prof.
Microbiology & Biotechnology, Ghent University, Centre for Industrial
Biotechnology and Biocatalysis (InBio.be), Belgium. |
|
Dr. Mark S.
Braiman, PhD.
Professor of Chemistry, Syracuse University, USA. |
|
Dr. Mikko
Paunio, MD PhD MHS.
Adjunct Professor in General Epidemiology, University of Helsinki. Medical Counselor Ministry
of Social Affairs and Health, Finland. |
|
Dr. Olaf
Dathe, Dr med. OBGYN, Munich, Germany. |
|
Dr. Manfred
Eggersdorfer, PhD. Professor for Healthy Ageing, University Medical Center
Groningen, The Netherlands. Member of the Advisory Board of the Johns Hopkins
Bloomberg School of Public Health. Disclosure: Head of
Nutrition Science and Advocacy, DSM Nutritional Products. Member of the scientific
board of PM International. |
|
Dr. Chris
Newton, PhD.
Research director, Centre for Immuno-Metabolism, Microbiome and Bio-energetic
Research (CIMMBER), UK. |
|
Dr. Doreen Brodmann, Dr med. Head of
Nephrology, Spitalzentrum Oberwallis, Switzerland. |
|
Dr. Srijit
Mishra, PhD,
Economics. Professor, Indira Gandhi Institute of Development Research,
Mumbai, India. |
|
Dr. Marco
Infante, MD. Adjunct
Professor of Endocrinology, UniCamillus - Saint Camillus International
University of Health Sciences, Rome, Italy. |
|
Dr. Jean-Marc Sabatier, PhD HDR. Director of
research at CNRS (French National Centre for Scientific Research), Institut
de NeuroPhysiopathologie (INP), Marseille, France. |
|
Dr. Mohsin
Sidat, MD PhD.
University Eduardo Mondlane, Mondlane, Mozambique. |
|
Dr. Pallavi
Devulapalli, MBBS MRCGP. Hospital Practitioner in Dermatology. GP, Vide Healthcare.
Norfolk, UK. |
|
Dr. Dimitrios T.
Papadimitriou,
MD PhD. Director,
Department of Pediatric-Adolescent Endocrinology & Diabetes, Athens
Medical Center, Greece. |
|
Dr. Bodo Schertel, Dr med. Professor,
Hochschule Mannheim, Germany. |
|
Dr. Jahit
Sacarlal, MD PhD MPH. Professor,
Department of Microbiology, Eduardo Mondlane University, Maputo, Mozambique. |
|
Dr. Espen
Haug, Phd.
Professor, School of Economics and Business, Norwegian University of Life
Sciences (NMBU), Norway. |
|
Dr. Martin
Hewison, PhD.
Professor of Molecular Endocrinology, Institute of Metabolism and Systems
Research, University of Birmingham, Birmingham, UK. Disclosure:
Received honorarium from Thornton Ross (UK) for online seminar. |
|
Dr. Damien
Downing, MBBS MRSB.
President, British Society for Ecological Medicine, UK. |
|
Dr. Linda A.
Linday, MD.
Assistant Clinical Professor of Pediatrics, Icahn School of Medicine at Mount
Sinai, New York, NY, USA. |
|
Dr.
Rose Anne Kenny, MD FRCP FRCPI FRCPEdin FTCD FESC MRIA.
Professor, Chair of Medical Gerontology, Trinity College, Dublin, Ireland. |
|
Dr. Mihkel Zilmer, Dr. med. Professor,
Medical Biochemistry, Head of Department of Biochemistry, Tartu University, Faculty
of Medicine, Estonia. |
|
Dr. Jaan Eha, MD PhD. Professor of
Cardiology, Tartu University, Faculty of Medicine, Estonia. |
|
Dr. Anna
Moore, MBBS
PgDipNutrMed, London, UK. |
|
Dr. Roger D. Seheult, MD. Assistant
Professor, Loma Linda University School of Medicine. Associate Professor, UC
Riverside School of Medicine. Cofounder, MedCram, USA. |
|
Dr. Jean-Claude
Souberbielle,
PhD PharmD. Former head
of Hormonology Laboratory, Necker Hospital, Paris, France. |
|
Dr. Emmanuelle
Faucon, MD, Toulon,
France. Former
Medical Affairs Director in Immunology and Virology, Bristol Myers Squibb. |
|
Dr. Aida
Santaolalla, PhD. Senior Data Scientist, Cancer Epidemiology, King's College
London, UK. |
|
Dr. Elisa Song, MD. Pediatrician, Belmont,
CA, USA. |
|
Dr. Mylene
Huynh, MD MPH.
Colonel (ret), USAF. Adjunct Assistant Professor, Department of Preventive
Medicine and Biometrics, Uniformed Services University of the Health
Sciences, USA. |
|
Dr. Yosef
Weisman, MD.
Professor. Retired head of Bone Desease Unit and the Vitamin D Lab, Tel Aviv
Souraski Medical Center, Faculty of Medicine, Tel Aviv University, Israel. |
|
Dr. Andrius
Bleizgys, MD PhD.
Lector of Clinic of Internal Diseases, Family Medicine and Oncology, Vilnius
University Faculty of Medicine, Vilnius, Lithuania. |
|
Dr. Keshav
Singhal, FRCS
MS(orth) M.Ch(orth). Professor, Consultant Orthopaedic Surgeon. Chair British
Association of Physicians of Indian Origin (BAPIO), Wales. Council Member
& Trustee, Swansea University. Fellow of Learned Society of Wales, UK. |
|
Dr. Gennadi
Glinsky, MD PhD.
Professor, Institute of Engineering in Medicine, University of California,
San Diego, La Jolla, USA. |
|
Dr. Eero Vasar, MD PhD. Professor of
Human Physiology, University of Tartu, Estonia. |
|
Dr. Frank C.
Church, PhD.
Professor of Pathology and Laboratory Medicine, University North Carolina
School of Medicine, Chapel Hill, NC, USA. |
|
Dr. Michael
J. A. Robb, MD. Physician, Oto-Neurologist, Robb Oto-Neurology Clinic, Phoenix,
Arizona. Past President, Association of American Physicians and Surgeons
(AAPS), USA. |
|
Dr. Giles
Duffield, PhD.
Associate Professor, Department of Biological Sciences & Eck Institute for
Global Health, University of Notre Dame, Notre Dame, IN, USA. |
|
Dr. Harry
Wichers, PhD.
Professor in Immune Modulation by Food, Wageningen UR, The Netherlands. |
|
Dr. Matthew
A. Nehs, MD.
Assistant Professor of Surgery, Harvard Medical School. Program Director, Harvard
Combined Endocrine Surgery Fellowship. USA. |
|
Dr. Hana
Fakhoury Hajeer, PhD. Associate Professor of Biochemistry,
Alfaisal University, Saudi Arabia. |
|
Dr. Fatme Al
Anouti, PhD
Biochemistry. Associate Professor, College of Natural and Health Sciences,
Zayed University, UAE. |
|
Dr. José C.
Tutor, PharmD PhD
MB. Pharmacology Unit, Health Research Institute, University Clinical
Hospital, Santiago de Compostela, Spain. |
|
Dr. Wolfgang
Schrott, PhD.
Professor (retired), Chemistry, Hochschule Hof University of Applied
Sciences, Germany. |
|
Dr. Brian
Lenzkes, MD,
Internal Medicine, San Diego, CA, USA. |
|
Dr. Ryan
(Nguyen) Hoang, MD. Resident Physician, Pediatrics, Children's Mercy Hospital,
Kansas City, Kansas, USA. Reddit Moderator & Editor at /r/science &
/r/coronavirus. |
|
Dr. Hayley A
Young, PhD.
Associate Professor, Nutrition and Behaviour, Swansea University, UK. |
|
Dr. Luis Lugones, PhD. Assistant Professor
Microbiology, Faculty of Sciences, Utrecht University, The Netherlands. |
|
Beth Ellen
DiLuglio, RDN LDN MS
in Human Nutrition from Columbia University College of Physicians and
Surgeons Institute of Human Nutrition. Former Associate Professor of
Nutrition, Palm Beach State College, Lake Worth, FL. Registered Dietitian
Nutritionist, Florida, USA. Disclosure: Researcher & writer for
OptimalDx.com. |
|
Dr. David
Benton, PhD DSc. Professor, Swansea
University, UK. |
|
Dr. Ljubiša Mihajlović, PhD,
Molecular biology. Professor, Academy of Technical and Educational Sciences,
Niš, Serbia. CEO, Geneinfo, Niš, Serbia. |
|
Dr. Huub
Savelkoul, PhD. Full Professor, Head, Cell Biology and Immunology Group,
Wageningen University, The Netherlands. |
|
Dr. Cicero
Galli Coimbra, MD PhD. Assistant Professor of Neurology and Neuroscience, Federal
University of São Paulo. President, Institute for Investigation and Treatment
of Autoimmunity, Brazil. Creator, "Coimbra Protocol" for autoimmune
diseases. |
|
Dr. Parag
Singhal, MD FRCP
FACP. Professor of Medicine, University of South Wales, UK. Consultant Endocrinologist. |
|
Dr. Meis
Moukayed, PhD
(Cantab), Professor of Health and Life Sciences, American University in
Dubai, Dubai, UAE. |
|
Dr. Linda
Bluestein, MD. Clinical Assistant Professor, Medical College of Wisconsin, USA. |
|
Dr. Alex
Bäcker, PhD,
Biology, Caltech, USA. |
|
Dr. Chad G. Kahl, MD SFS FAAFP. Clinical
Assistant professor of Medicine, Uniformed Services University. Chief Medical Officer,
Pentagon Flight Medicine Clinic, USA. |
|
Dr. Renu Mahtani, MD FMNM. Consulting
Physician and Founder, Autoimmunity Treatment Center, Pune, India. |
|
Dr. Andrea
Deledda, PhD.
Department of Medical Sciences and Public Health, University of Cagliari. Nutritionist, Obesity
Center, University Hospital of Cagliari, Italy. |
|
Dr. Alessandro
D. Santin, MD. Professor of
Obstetrics & Gynecology, Yale School of Medicine, New Haven, CT, USA. |
|
Dr. Kelly
McCann, MD MPH.
Physician and President, The Spring Center, Costa Mesa, CA, USA. |
|
Dr.
Alessandro Comandone, MD. Director, Dept. of Oncology, San Giovanni
Bosco Hospital Turin, Italy. |
|
Dr. Endrit
Shahini, MD MSC
FPO-IRCCS. Candiolo Cancer
Institute, Candiolo (Torino), Italy. |
|
Dr. Phillip
C. Gioia, MD MPH FAAP
FACPM, Certificate in Clinical Informatics. Medical Director of Cayuga
County Health Department, NY, USA. |
|
Dr. Edward
Jude, MBBS MD
FRCP. Professor of Medicine, University of Manchester, UK. |
|
Dr. Jaimela J
Dulaney, MD.
Cardiology, Primary Care, Nutrition, Port Charlotte, Florida, USA. |
|
Dr. Sudeepta
Varma, MD DFAPA. Clinical
Assistant Professor, Department of Psychiatry, NYU Grossman School of
Medicine, NY, USA. |
|
Dr. Olga
Louro, MD PhD.
Clínical Laboratory, University Clínical Hospital, Santiago de Compostela,
Spain. |
|
Dr. Joerg
Velker, PhD. Chief
Patent Counsel, Idorsia Pharmaceuticals, Switzerland. Former Senior Lab Head,
Medicinal Chemistry, Actelion. |
|
Dr. Maartje van Putten, PhD. Member of
European Parliament 1989-99, Committee on Environment Heath & Consumer
Affairs. Chair, OECD NCP,
The Netherlands. |
|
Dr. Maria
Joana Pinto, Teacher (Docente), Medical Course, Pará State University (UEPA),
Marabá Campus, Pará, Brazil. |
|
Dr. Sergio Luis Menéndez Lucero, MD PhD. General
Practitioner, Autoimmune Focus. Spain. |
|
Dr. Jean-Michel
Wendling, MD,
Occupationnal Médecine, ACST, Strasbourg, France. |
|
Dr. Georg
Moessmer (Mößmer), Dr med., Hemostaseology, Institute for Clinical
Chemistry and Pathobiochemistry, Technical University of Munich, Munich,
Germany. |
|
Dr. Haladia
Pessotti de Campos Simião, MD. Endocrinologist, Clinical Nutritionist, &
General Practitioner, São Paulo, Brazil. |
|
Dr. Franklin
Roy Long, MD MPH/TM
ABOIM. Family Medicine, Vacaville, CA, USA. |
|
Dr. Stelios
Bekiros, PhD.
Professor, European University Institute, Department of Economics, Florence,
Italy. Affiliate Research Fellow, IPAG Business School. Senior Fellow, Rimini
Centre for Economic Analysis (RCEA). |
|
Dr. Farhad
Zangeneh, MD. Medical
Director & CMO, Endocrine, Diabetes and Osteoporosis Clinic, Washington,
DC, USA. |
|
Dr. Adrian F
Gombart, PhD. Principal
Investigator, Linus Pauling Institute, Professor, Department of Biochemistry
and Biophysics, Oregon State University, USA. |
|
Dr. Sari
Arponen, MD PhD.
Internist and Infectious Diseases Specialist, Associate Professor, Camilo
José Cela University, Madrid. University Hospital of Torrejón, Spain. |
|
Dr. Naomi
Parrella, MD FAAFP
Dipl.ABOM. Assistant Professor. Rush University Medical Center, Chicago, IL, USA. |
|
Dr. Jens
Freese, Doctor of
Natural Sciences (Dr rer nat, Germany). Dr. Freese Institute for Sport and
Nutritional Immunology, Cologne, Germany. |
|
Dr. Luciano G Nina, MD. Assistant Professor,
Faculdade de Medicina de Jundiaí, Sao Paulo, Brazil. |
|
Dr. Robert M Hansen, MD. Internal
Medicine, Critical Care Medicine, Anesthesiology. Managing Partner, Redding
Anesthesia Associates Medical Group, Redding, CA, USA. |
|
Dr. Canan
Karatay, MD.
Professor of Heart and Internal Diseases, former Rector of Istanbul Bilim
(Science) University, Istanbul, Turkey. |
|
Dr. David
Brownstein, MD. Clinical Professor of Internal Medicine, Wayne State University
School of Medicine. Medical Director, Center for Holistic Medicine, West
Bloomfield, Michigan, Michigan, USA. |
|
Dr. Vassaras
Alexandros-Charalampos, MD, NeuroImmunology. Papageorgiou General
Hospital, Greece. |
|
Dr. Sarfraz
Zaidi, MD FACP FACE. Endocrinologist,
Camarillo, CA. Former Assistant Clinical Professor of Medicine, UCLA, USA. |
|
Dr. Maria
Morello, PhD,
Clinical Biochemistry and Molecular Biology. Senior Researcher, Department of
Experimental Medicine, Tor Vergata University, Rome University Hospital,
Rome, Italy. |
|
Dr. Bryan A
Stepanenko, MD MPH IFMCP. Active Duty US Army, Member of Task Force Resilience,
Army Public Health, Primary Care Physician, USA. |
|
Dr. Yamile
Mussa, MD.
Pediatrician, Autism Specialist, Bolívar, Venezuela. |
|
Dr. Joseph
Parambil, MD.
Pulmonologist, Cleveland Clinic, Respiratory Institute, and Assistant
Professor of Medicine, Cleveland Clinic, Lerner College of Medicine,
Cleveland, OH, USA. |
|
Dr. David
Norman Grant, Former Consultant Neurosurgeon, Great Ormond St. Hospital and
National Hospital for Neurology and Neurosurgery, Queen Square, London, UK. |
|
Dr. Ellen C G
Grant, MBChB,
DObstRCOG, Retired Physician and Medical Gynaecolgist, Kingston upon Thames,
UK. |
|
Dr. Peter
Moon, PhD.
Professor Emeritus, Biomateriels Director, Department of General Practice,
Virginia Commonwealth University, School of Dentistry, Richmond, VA, USA. |
|
Dr. Ram Yogendra, MD MPH. Anesthesiologist,
Private Practice. Founder & Director, ECA Wellness, Rhode Island, USA. |
|
Dr. Laura Di
Renzo, PhD. Professor,
Department of Biomedicine and Prevention, University of Rome Tor Vergata,
Italy. |
|
Dr. Theo van Kempen, Dr Ir, PhD. Adjunct
Professor, North Carolina State University, USA. |
|
Dr. Laurence
S. Harbige, PhD CBiol FRSB. Deputy Director of the Lipidomics and Nutrition
Research Centre (LNRC) and Senior Lecturer in the School of Human Sciences,
London Metropolitan University, UK. |
|
Dr. Björn
Hammarskjöld, MD, PhD in Biochemistry. Assistant professor in Pediatrics at
Strömstad Academy, Östervåla, Sweden. |
|
Dr. Birgit
Strodel, PhD.
Professor, Computational Biochemistry, Research Centre Jülich, Jülich, and
Heinrich Heine University, Düsseldorf, Germany. |
|
Dr. Pearl
Grimes, MD FAAD.
Founder & Medical Director, Vitiligo & Pigmentation Institute of
Southern California. Chief
Dermatologist, Versicolor Technologies. Former Clinical Professor of
Dermatology, UCLA, USA. |
|
Dr. Julian
Walters, MBBChir,
DSc. Professor of Gastroenterology, Imperial College London, UK. |
|
Dr. Patrick
Chambers, MD.
Laboratory Director (ret), Torrance Memorial Medical Center, Torrance, CA,
USA. |
|
Dr. David
Sinclair, PhD.
Professor of Genetics, Co-Director, Paul F. Glenn Center for the Biology of
Aging, Harvard Medical School, Boston, MA, USA. Disclosure: List of past
& present affiliations. |
115 professors
131 signatories
with medical degrees
116 signatories
with PhDs or equivalent or higher degrees
128 signatories
with personal intakes of at least 4000 IU per day
29 signatories
with personal intakes of at least 10,000 IU per day
33 countries
Our goal is to
change policy and standard of care to save lives and help mitigate the
pandemic, not to create the longest possible list of names. At this point, we
have enough PhDs and medical doctors. We welcome additional signature requests
from those especially well placed to help convince government decision makers
to implement the calls-to-action enumerated in the letter, such as senior
professors in areas such as immunology, infectious disease, endocrinology, or
vitamin D research, or related areas, or such as officials at national or
international public health bodies (CDC, WHO, etc.) or members of COVID-19/pandemic
tasks forces for large jurisdictions. If you are such an authority, please fill
out this form. If you are
not but would like to help, please spread the word via social media, directly
to your local public health and political leaders, and directly to the most
senior people that you have a personal or professional route to that might be
able to help.
info@vitaminDforAll.org
Bron: https://vitamind4all.org/letter.html
